Alexandra Acco
Overview
Explore the profile of Alexandra Acco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stipp M, Acco A
Gene
. 2025 Jan;
941():149209.
PMID: 39755262
The oncoprotein c-Myc is expressed in all breast cancer subtypes, but its expression is higher in triple-negative breast cancer (TNBC) compared to estrogen receptor (ER+), progesterone receptor (PR+), or human...
2.
de Oliveira K, Abboud K, Radulski D, Faria B, Galindo C, Pereira G, et al.
Int J Biol Macromol
. 2024 Aug;
278(Pt 3):134590.
PMID: 39127269
This study investigated the antitumoral, anti-inflammatory and oxidative effects of polysaccharides from tucum (Bactris setosa, TUC) using the Ehrlich carcinoma as a tumor model. Additionally, the glycogen content, cytochrome P...
3.
Waltrick A, Radulski D, de Oliveira K, Acco A, Verri W, Cunha J, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2024 May;
133:111028.
PMID: 38754696
Protectin DX (PDX), a specialized pro-resolving lipid mediator, presents potential therapeutic applications across various medical conditions due to its anti-inflammatory and antioxidant properties. Since type-1 diabetes mellitus (T1DM) is a...
4.
Radulski D, Stipp M, Galindo C, Acco A
Transl Breast Cancer Res
. 2024 May;
4:22.
PMID: 38751464
Background And Objective: Breast cancer is the most prevalent cancer worldwide, responsible for a large number of deaths, especially among women. Therapeutic options for breast cancer include surgery, radiotherapy, chemotherapy,...
5.
Lopes M, Baptistella G, Nunes G, Ferreira M, Cunha J, de Oliveira K, et al.
Pharmaceuticals (Basel)
. 2024 Apr;
17(4).
PMID: 38675446
Diabetes mellitus (DM) complications are a burden to health care systems due to the associated consequences of poor glycemic control and the side effects of insulin therapy. Recently. adjuvant therapies,...
6.
Tatsch J, Furman D, Nobre R, Wurzer K, da Silva L, Picheth G, et al.
Epigenomics
. 2024 Jan;
15(24):1309-1322.
PMID: 38174426
Dulaglutide emerged as a promising therapeutic option for diabetes mellitus Type 2 (DM2). Owing to epigenetic similarities between the pathophysiology of DM2 and breast cancer (BC), we investigated the antitumor...
7.
Galindo C, Milani L, de Lima L, Adami E, Go S, de Noronha L, et al.
Chem Biol Interact
. 2023 Nov;
387:110790.
PMID: 37939893
Breast cancer is a high-magnitude public health problem, continually challenging physicians and scientists worldwide in the field of drug therapy. 4-nitrochalcone (4NC) is a phenolic compound that has promising antitumor...
8.
Stipp M, Kulik J, Corso C, Galindo C, Adami E, Evangelista A, et al.
Int J Biol Macromol
. 2023 Apr;
240:124385.
PMID: 37060983
The soluble fraction of polysaccharides from cabernet franc red wine (SFP) previously showed antitumoral effects by modulating the immune system. The present study tested the hypothesis that the SFP can...
9.
de Lima L, Ganzella F, Cardoso G, Pires V, Chequin A, Santos G, et al.
Chem Biol Interact
. 2023 Apr;
378:110480.
PMID: 37059214
Breast cancer is one of the most common types of cancer in the world and current therapeutic strategies present severe drawbacks. l-carvone (CRV), a monoterpene found in Mentha spicata (spearmint),...
10.
Oliveira N, Dos Santos A, Corso C, Galindo C, Adami E, Malaquias da Silva L, et al.
J Nutr Biochem
. 2022 Dec;
113:109253.
PMID: 36565967
The present study characterized oligosaccharide compounds (Oligo) in Cabernet Franc red wine and investigated its antineoplastic effects against mammary tumor cells in vivo and in vitro, isolated or in combination...